Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix and DeCode Collaborate on Gene Tests for Drug Response in Common Diseases


Affymetrix and DeCode Genetics have signed an agreement to use Affymetrix GeneChip technology to develop DNA-based tests for patient response to common disease treatments.

The companies will conduct gene expression analysis on clinical trial populations to discover gene expression patterns corresponding to responses to drugs for high cholesterol, depression, asthma, hypertension, breast cancer, schizophrenia, and migraine, and then develop and market chip-based diagnostic assays for drug response patterns, said DeCode’s CEO Kari Stefansson.

DeCode has already tested populations of responders and non-responders to steroids for asthma with GeneChip arrays and found 400 differentially expressed genes in these populations, Stefansson said. “Then we used our own proprietary mathematical algorithms to select out 24 genes that gave well over 90 percent predictions of responders and non-responders to steroids. This is the paradigm that we are going to follow in our attempt to develop pharmacogenomic [assays] for a large number of the most commonly used drugs in our society.’

Under the agreement, Affymetrix will supply the GeneChips, and DeCode will supply the population genetics and bioinformatics expertise. The companies will share any revenues from DNA-based tests the parties develop.

When the companies have developed specific assays, Affymetrix will also develop pharmacogenomic chip assays that contain only the relevant response-related genes, Stefansson said. “We want to make [the assay] cheap, make it effective and Affymetrix has been put in a particularly effective position to develop all kinds of combinations of chips with the genes.’


The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.